By Cecilia Butini 

Sanofi SA said Wednesday that net profit and sales fell for the first quarter of 2021.

The French pharmaceutical major posted net profit of 1.57 billion euros ($1.90 billion), down from EUR1.68 billion a year earlier, on sales that fell to EUR8.59 billion from EUR8.97 billion.

Sales of key growth driver Dupixent grew 45.6% in the quarter despite the adverse environment created by the coronavirus pandemic, Sanofi said.

Business net income--a key profit metric that excludes some items--came in at EUR2.02 billion, compared with EUR2.04 billion. Business earnings per share were EUR1.61, a 5.2% increase from a year earlier.

The company backed its outlook for 2021, saying that it expects business earnings per share to grow by a high-single digit at constant exchange rates, barring unforeseen events.


Write to Cecilia Butini at


(END) Dow Jones Newswires

April 28, 2021 02:08 ET (06:08 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.